BNP Paribas Financial Markets’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.54M | Buy |
|
|||||
|
2025
Q1 | $8.52M | Sell |
|
|||||
|
2024
Q4 | $10.6M | Buy |
|
|||||
|
2024
Q3 | $2.62M | Buy |
|
|||||
|
2024
Q2 | $1.95M | Sell |
|
|||||
|
2024
Q1 | $2.66M | Buy |
|
|||||
|
2023
Q4 | $1.55M | Buy |
|
|||||
|
2023
Q3 | $1.08M | Buy |
|
|||||
|
2023
Q2 | $407K | Sell |
|
|||||
|
2023
Q1 | $906K | Buy |
|
|||||
|
2022
Q4 | $615K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $673K | Buy |
|
|||||
|
2022
Q1 | $560K | Sell |
|
|||||
|
2021
Q4 | $1.76M | Buy |
|
|||||
|
2021
Q3 | $1.46M | Buy |
|
|||||
|
2021
Q2 | $738K | Buy |
|
|||||
|
2021
Q1 | $600K | Buy |
|
|||||
|
2020
Q4 | $405K | Buy |
|
|||||
|
2020
Q3 | $286K | Sell |
|
|||||
|
2020
Q2 | $637K | Sell |
|
|||||
|
2020
Q1 | $2.26M | Buy |
|
|||||
|
2019
Q4 | $296K | Buy |
|
|||||
|
2019
Q3 | $246K | Buy |
|
|||||
|
2019
Q2 | $218K | Sell |
|
|||||
|
2019
Q1 | $398K | Buy |
|
|||||
|
2018
Q4 | $38.8K | Sell |
|
|||||
|
2018
Q3 | $186K | Sell |
|
|||||
|
2018
Q2 | $495K | Sell |
|
|||||
|
2018
Q1 | $900K | Sell |
|
|||||
|
2017
Q4 | $823K | Sell |
|
|||||
|
2017
Q3 | $1.04M | Buy |
|
|||||
|
2017
Q2 | $648K | Sell |
|
|||||
|
2017
Q1 | $4.34M | Buy |
|
|||||
|
2016
Q4 | $257K | Buy |
|
|||||
|
2016
Q3 | $170K | Sell |
|
|||||
|
2016
Q2 | $234K | Buy |
|
|||||
|
2016
Q1 | $77.3K | Sell |
|
|||||
|
2015
Q4 | $96.2K | Sell |
|
|||||
|
2015
Q3 | $110K | Buy |
|
|||||
|
2015
Q2 | $48.5K | Buy |
|
|||||
|
2015
Q1 | $8.23K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $19.5K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $509 | Sell |
|
|||||
|
2013
Q4 | $1.51K | Buy |
|